Orum Therapeutics
The Project Team Leader will drive oncology drug discovery programs from target validation through IND, translating strategic direction into actionable plans and providing scientific leadership to a small team. This role bridges hands‑on execution and research strategy, overseeing biology strategy, in‑vitro and in‑vivo studies, and cross‑functional collaboration to advance candidates toward the clinic.
Headquarters
Lexington, Massachusetts, United States
Company Size
11-50 employees
Founded
2016
Orum Therapeutics is a biotechnology company developing cell‑specific, targeted protein degraders that combine the selectivity of antibody targeting with the mechanism of targeted protein degradation. Their platform aims to selectively eliminate disease‑relevant proteins in defined cell types, expanding the druggable proteome while improving therapeutic precision and safety. Orum advances proprietary degrader therapeutics and works with partners to translate its technology into new treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Orum Therapeutics.
29% above the average for this role
Translational Biologist
Isomorphic Labs
Associate Principal Scientist
MSD
VP, Head of Preclinical Development
Legend Biotech
Senior Principal Scientist - Amylin Biology & Receptor Pharmacology
Novo Nordisk A/S
Cancer Biology Postdoctoral Fellow
Mct Hiring
Senior Director, AIRx Discovery Biology Lead
BioLife Plasma Services